Different Routes of Proton Pumps Inhibitors Co-Administration have Significant Impact on Mycophenolate Acid (MPA) Serum Levels in Heart Transplant Recipients (original) (raw)

Proton Pump Inhibitor Co-medication Reduces Mycophenolate Acid Drug Exposure in Heart Transplant Recipients

Marcus-André Deutsch

2009

View PDFchevron_right

Proton Pump Inhibitor Co-medication Reduces Active Drug Exposure in Heart Transplant Recipients Receiving Mycophenolate Mofetil

Arnt Kristen

Transplantation Proceedings, 2010

View PDFchevron_right

Pharmacokinetics and variability of mycophenolic acid from enteric-coated mycophenolate sodium compared with mycophenolate mofetil in de novo heart transplant recipients

M. Hummel, Gino Gerosa

Clinical Transplantation, 2007

View PDFchevron_right

Therapeutic Monitoring of Mycophenolate Mofetil in Organ Transplant Recipients

Pierre Wallemacq

Clinical Pharmacokinetics, 2002

View PDFchevron_right

Correlation of mycophenolic acid pharmacokinetic parameters with side effects in Chinese kidney transplant recipients treated with mycophenolate mofetil

Raf Schepers

Transplantation Proceedings, 2004

View PDFchevron_right

Pharmacokinetics and Pharmacodynamics of Intensified versus Standard Dosing of Mycophenolate Sodium in Renal Transplant Patients

Petra Glander

Clinical Journal of The American Society of Nephrology, 2010

View PDFchevron_right

Pharmacokinetic Basis for the Efficient and Safe Use of Low-Dose Mycophenolate Mofetil in Combination with Tacrolimus in Kidney Transplantation

Pierre Wallemacq

2000

View PDFchevron_right

Dose-normalization for exposure to mycophenolic acid and the early clinical outcome in patients taking tacrolimus after heart transplantation

Jun-Neng Roan

Annals of Transplantation, 2013

View PDFchevron_right

Lack of Correlation Between MMF Dose and MPA Level in Pediatric and Young Adult Cardiac Transplant Patients: Does the MPA Level Matter?1

Dennis Crowley

American Journal of Transplantation, 2004

View PDFchevron_right

The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy

Domingo Hernández

Nephrology Dialysis Transplantation, 2009

View PDFchevron_right

Concomitant Proton Pump Inhibitors With Mycophenolate Mofetil and the Risk of Rejection in Kidney Transplant Recipients

Jorge Ortiz

Transplantation, 2014

View PDFchevron_right

Pharmacokinetics and pharmacodynamics of mycophenolate sodium (EC-MPS) co-administered with cyclosporine in the early-phase post-kidney transplantation

Eberhard Wieland, Catherine M T Sherwin, Alexander Vinks

Clinical Transplantation, 2012

View PDFchevron_right

Pharmacokinetics of Mycophenolic Acid after Mycophenolate Mofetil Administration in Liver Transplant Patients Treated with Tacrolimus

Vijay Warty

The Journal of Clinical Pharmacology, 2001

View PDFchevron_right

Effect of T-tube clamping on the pharmacokinetics of mycophenolic acid in liver transplant patients on oral therapy of mycophenolate mofetil

Vijay Warty, Shimin Zhang

Liver Transplantation and Surgery, 1999

View PDFchevron_right

Therapeutic Drug Monitoring of Mycophenolic Acid as a Precision Medicine Tool for Heart Transplant Patients: Results of an Observational Pharmacokinetic Pilot Study

massimo baraldo

Pharmaceutics

View PDFchevron_right

Value of therapeutic drug monitoring of MMF therapy in pediatric transplantation

Guido Filler

Pediatric Transplantation, 2006

View PDFchevron_right

The Rationale for and Limitations of Therapeutic Drug Monitoring for Mycophenolate Mofetil in Transplantation

Leslie Shaw

Transplantation, 2005

View PDFchevron_right

Pharmacokinetic, pharmacodynamic, and outcome investigations as the basis for mycophenolic acid therapeutic drug monitoring in renal and heart transplant patients

Magdalena Korecka

Clinical Biochemistry, 2001

View PDFchevron_right

Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant

M. Durlik

Journal of Clinical Pharmacy and Therapeutics, 2006

View PDFchevron_right

Comparative pharmacokinetic study of two mycophenolate mofetil formulations in stable kidney transplant recipients

Petra Reinke

Transplant International, 2012

View PDFchevron_right

Influence of Proton Pump Inhibitors on Mycophenolic Acid Pharmacokinetics in Patients With Renal Transplantation and the Relationship With Cytochrome 2C19 Gene Polymorphism

Filiz Aydin

Transplantation Proceedings, 2017

View PDFchevron_right

Mycophenolate Mofetil Pharmacokinetic Monitoring in Pediatric Kidney Transplant Recipients

Luca Strologo

Transplantation Proceedings, 2005

View PDFchevron_right

Quantification of Mycophenolic Acid in Plasma Samples Collected during and Immediately after Intravenous Administration of Mycophenolate Mofetil

E. Schütz

Clinical Chemistry, 2001

View PDFchevron_right

The need of mycophenolic acid monitoring in long-term renal transplants

Paschoalina Romano

Clinical Transplantation, 2005

View PDFchevron_right

A Double Absorption-Phase Model Adequately Describes Mycophenolic Acid Plasma Profiles in De Novo Renal Transplant Recipients Given Oral Mycophenolate Mofetil

Yvon Lebranchu, Jean Debord

Clinical Pharmacokinetics, 2005

View PDFchevron_right

The CLEAR Study: A 5-day, 3-g Loading Dose of Mycophenolate MofetilversusStandard 2-g Dosing in Renal Transplantation

Ahmed Shoker

Clinical Journal of the American Society of Nephrology, 2010

View PDFchevron_right

Pharmacokinetics of mycophenolate mofetil are influenced by concomitant immunosuppression

Guido Filler

Pediatric Nephrology, 2000

View PDFchevron_right

Comparing Mycophenolate Mofetil Regimens for de Novo Renal Transplant Recipients: The Fixed-Dose Concentration-Controlled Trial

Anders Hartmann

Transplantation, 2008

View PDFchevron_right

Pharmacokinetics of Mycophenolic Acid in Kidney Transplant Patients Receiving Sirolimus Versus Cyclosporine

Antoine Coquerel

Transplantation Proceedings, 2005

View PDFchevron_right

Time-dependent clearance of mycophenolic acid in renal transplant recipients

Teun Van Gelder

British Journal of Clinical Pharmacology, 2007

View PDFchevron_right

INTRAVENOUS MYCOPHENOLATE MOFETIL (MMF): SAFETY, TOLERABILITY, AND PHARMACOKINETICS

Dilip Kittur

Transplantation, 1999

View PDFchevron_right